Oral chirality-engineered nanozyme protects the heart by modulating the gut-heart axis (IMAGE)

Science China Press

Oral chirality-engineered nanozyme protects the heart by modulating the gut-heart axis

Caption

Researchers developed an orally administered chirality-engineered nanozyme (L-AENC) that targets the intestine, restores gut microbiota and host metabolism, and alleviates doxorubicin-induced cardiotoxicity through the gut-heart axis without compromising anticancer efficacy.

Credit

©Science Bulletin

Usage Restrictions

use with credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.